Technology & Methodology
Diagnostic & Prognostic Tools for Personalized Medicine
Our novel, proprietary technology analyzes a specific part of an individual’s unique DNA (their telomeres) to determine how a disease will progress and if a patient will respond to treatment.
This information enables clinicians to measure the appropriateness and effectiveness of different treatments for specific patients.
About 3D Telomere Analysis
3D Signatures is currently developing 5 diagnostic and prognostic products for cancers and neurological disorders.
|Hodgkin’s Lymphoma||3D telo-HL||●|
|Prostate Cancer||3D Telo-PC||●|
|Multiple Myeloma||3D Telo-MM||●|
|Lung Cancer||3D Telo-LC||●|